Accuracy of Monoclonal Stool Antigen Test for the Diagnosis of H. pylori Infection: A Systematic Review and Meta-Analysis

Gisbert, Javier P.; de la Morena, Felipe; Abraira, Víctor
August 2006
American Journal of Gastroenterology;Aug2006, Vol. 101 Issue 8, p1921
Academic Journal
OBJECTIVE: To perform a systematic review and a meta-analysis of accuracy of monoclonal stool antigen test (SAT) for the diagnosis of Helicobacter pylori infection. METHODS: Selection of studies: assessing the accuracy of monoclonal SAT for the diagnosis of H. pylori infection. Search strategy: electronic and manual bibliographical searches. Data extraction: independently done by two reviewers. Data synthesis: meta-analyses combining the sensitivities, specificities, and likelihood ratios (LRs) of the individual studies. RESULTS: Twenty-two studies, including 2,499 patients, evaluated the monoclonal SAT before eradication therapy. Pooled sensitivity, specificity, LR+, and LR− were: 0.94 (95% CI 0.93–0.95), 0.97 (0.96–0.98), 24 (15–41), and 0.07 (0.04–0.12). The accuracy of both monoclonal and polyclonal SAT was evaluated together in 13 pretreatment studies, and higher pooled sensitivity was demonstrated with the monoclonal technique (0.95 vs 0.83). Twelve studies, including 957 patients, assessed the monoclonal SAT to confirm eradication after therapy. Pooled sensitivity, specificity, LR+, and LR− were 0.93 (0.89–0.96), 0.96 (0.94–0.97), 17 (12–23), and 0.1 (0.07–0.15). Both tests were evaluated together in eight post-treatment studies and, again, the monoclonal technique showed higher sensitivity (0.91 vs 0.76). Heterogeneity among studies disappeared when a single outlier study was excluded. Subanalysis depending on the reference method, the study population, or the study quality showed similar results. CONCLUSION: Monoclonal SAT is an accurate noninvasive method both for the initial diagnosis of H. pylori infection and for the confirmation of its eradication after treatment. The monoclonal technique has higher sensitivity than the polyclonal one, especially in the post-treatment setting.


Related Articles

  • Seven versus Ten Days of Rabeprazole Triple Therapy for Helicobacter pylori Eradication: A Multicenter Randomized Trial. Calvet, X; Ducons, J.; Bujanda, L; Bory, F.; Montserrat, A.; Gisbert, J. P. // American Journal of Gastroenterology;Aug2005, Vol. 100 Issue 8, p1696 

    BACKGROUND: Ten-day triple therapy is somewhat more effective than 7-day treatment for curing Helicobacter pylori infection. Recent studies have suggested that rabeprazole—a proton pump inhibitor with fast onset of acid inhibition—could raise the efficacy of 7-day therapies to the...

  • FDA Approves Breath Test for H. Pylori Infection. Preboth, Monica // American Family Physician;11/15/2001, Vol. 64 Issue 10, p1768 

    Reports on the approval of Breathtek UBT, a new breath test that detects active Helicobacter pylori infection by the United States Food and Drug Administration. Approval of the breath test for the initial diagnosis and for confirmation that the infection has been cured after treatment; How the...

  • Helicobacter pylori Infection. Delaney, Brendan C.; Moayyedi, Paul; Forman, David // American Family Physician;6/1/2003, Vol. 67 Issue 11, p2359 

    Focuses on Helicobacter (H.) pylori infection. Effects of treatments; Background on H. pylori; Prevalence; Risk factors.

  • Comparación de la prueba de antígenos fecales (Elisa) y test de aliento de la urea frente a histología para el diagnóstico de Helicobacter pylori: Revisión sistemática de la literatura. Poveda, Yuli Carreño; Reyes, Marcela Mercado; Trespalacios, Alba Alicia; Otero, William // Revista Colombiana de Gastroenterología;Oct2009, Vol. 24 Issue 4, p373 

    This is a systematic review of literature of the results of sensibility (S) specificity (E), (VPP) positive predictive value, and (VPN) negative predictive value, of original articles published between 2003 and 2008, of the test of fecal antigens and urea breath test with the hematoxilin and...

  • Clinical Findings and Prevalence of Helicobacter Pylori in Patients with Gastritis B in Al-Basrah Governorate. Alsaimary, Ihsan; Al-Sadoon, Maysloon; Jassim, Abdulmohsin; Hamadi, Saad // Oman Medical Journal;Jul2009, Vol. 24 Issue 3, p208 

    Objectives: To detect the prevalence of H. pylori in patients with gastritis B. Methods: This study involved 58 patients (group A) with gastritis B attending the Al-Sadder teaching hospital from January to November 2008. 120 of family's patients (group B) and normal 20 people, 10 males 10...

  • Helicobacter pylori Infection and Risk of Lung Cancer: A Meta-Analysis. Mounika, Pulikonda // Lung Cancer International;2013, p1 

    Background. Recent evidence showed that Helicobacter pylori seropositivity is a risk factor for gastric and several other cancers. However, evidence on H. pylori infection and risk of lung cancer has been controversial, with a limited number of underpowered studies. We therefore examined the...

  • The Prevalence of Helicobacter pylori Infection in the Peoples Republic of China. Li, Y. Y.; Hu, P. J.; Du, G. G.; Hazell, S. L. // American Journal of Gastroenterology;Apr1991, Vol. 86 Issue 4, p446 

    Meta-analysis on data from 16 (two volunteer and 14 endoscopic) studies has been performed to investigate the prevalence of Helicobacter pylori infection in the stomachs of individuals within the Peoples Republic of China. In this survey covering 2216 cases (89 volunteers and 2127 endoscopy...

  • Natural Transformation of Helicobacter pylori Involves the Integration of Short DNA Fragments Interrupted by Gaps of Variable Size. Lin, Edward A.; Xue-Song Zhang; Levine, Steven M.; Gill, Steven R.; Falush, Daniel; Martin J.6Blaser // PLoS Pathogens;Mar2009, Vol. 5 Issue 3, p1 

    Helicobacter pylori are gram-negative bacteria notable for their high level of genetic diversity and plasticity, features that may play a key role in the organism's ability to colonize the human stomach. Homeologous natural transformation, a key contributor to genomic diversification, has been...

  • Mini-Dose (1-μCi) 14C-Urea Breath Test for the Detection of Helicobacter pylori. Raju, G. S.; Smith, M. J.; Morton, D.; Bardhan, K. D. // American Journal of Gastroenterology;Jul1994, Vol. 89 Issue 7, p1027 

    Objectives: To develop and evaluate a mini-dose (1-µCi) 14C-urea breath test (UBT), using a simplified protocol. Methods: Fasting patients (n = 95) were given a drink of 1 µCo (37 kBq) of 14C-urea. Samples of breath carbon dioxide (2 mmol) were collected at 10, 20, and 30 min later by...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics